Rank | Gene Set | Z-score |
---|---|---|
1 | signal peptide processing (GO:0006465) | 6.50268241 |
2 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 6.10855670 |
3 | ATP synthesis coupled proton transport (GO:0015986) | 5.81358417 |
4 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 5.81358417 |
5 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 5.70612168 |
6 | ribosomal small subunit assembly (GO:0000028) | 5.25011812 |
7 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 5.16323668 |
8 | cotranslational protein targeting to membrane (GO:0006613) | 5.15366704 |
9 | respiratory electron transport chain (GO:0022904) | 5.11670108 |
10 | protein targeting to ER (GO:0045047) | 5.08158015 |
11 | electron transport chain (GO:0022900) | 5.02776220 |
12 | protein localization to endoplasmic reticulum (GO:0070972) | 4.90925741 |
13 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 4.80914377 |
14 | protein complex biogenesis (GO:0070271) | 4.70795240 |
15 | DNA deamination (GO:0045006) | 4.61123392 |
16 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 4.41273014 |
17 | NADH dehydrogenase complex assembly (GO:0010257) | 4.41273014 |
18 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 4.41273014 |
19 | GDP-mannose metabolic process (GO:0019673) | 4.39971438 |
20 | respiratory chain complex IV assembly (GO:0008535) | 4.34784290 |
21 | protein neddylation (GO:0045116) | 4.25284274 |
22 | ribosomal small subunit biogenesis (GO:0042274) | 4.23006530 |
23 | mitochondrial respiratory chain complex assembly (GO:0033108) | 4.22775065 |
24 | viral transcription (GO:0019083) | 4.21492635 |
25 | proteasome assembly (GO:0043248) | 4.10501600 |
26 | GTP biosynthetic process (GO:0006183) | 4.09560930 |
27 | translational termination (GO:0006415) | 4.08670575 |
28 | chaperone-mediated protein transport (GO:0072321) | 4.01529036 |
29 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.96151849 |
30 | platelet dense granule organization (GO:0060155) | 3.92738450 |
31 | translation (GO:0006412) | 3.87175516 |
32 | cullin deneddylation (GO:0010388) | 3.86197109 |
33 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.85451099 |
34 | Golgi transport vesicle coating (GO:0048200) | 3.84264008 |
35 | COPI coating of Golgi vesicle (GO:0048205) | 3.84264008 |
36 | protein deneddylation (GO:0000338) | 3.81691166 |
37 | cytochrome complex assembly (GO:0017004) | 3.79853016 |
38 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.74895263 |
39 | regulation of mitochondrial translation (GO:0070129) | 3.70381115 |
40 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.67168484 |
41 | rRNA modification (GO:0000154) | 3.66148459 |
42 | protein maturation by protein folding (GO:0022417) | 3.65777786 |
43 | peptidyl-histidine modification (GO:0018202) | 3.63987531 |
44 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.62746982 |
45 | guanosine-containing compound biosynthetic process (GO:1901070) | 3.62283661 |
46 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.61405795 |
47 | positive regulation of ligase activity (GO:0051351) | 3.60572261 |
48 | mannosylation (GO:0097502) | 3.56595867 |
49 | translational elongation (GO:0006414) | 3.55527256 |
50 | sequestering of actin monomers (GO:0042989) | 3.54385942 |
51 | hydrogen transport (GO:0006818) | 3.52049013 |
52 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.51102826 |
53 | UTP biosynthetic process (GO:0006228) | 3.48486072 |
54 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.44729683 |
55 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.44007412 |
56 | termination of RNA polymerase III transcription (GO:0006386) | 3.44007412 |
57 | establishment of integrated proviral latency (GO:0075713) | 3.43358609 |
58 | maturation of SSU-rRNA (GO:0030490) | 3.42415559 |
59 | viral life cycle (GO:0019058) | 3.39364327 |
60 | protein retention in ER lumen (GO:0006621) | 3.38749983 |
61 | protein targeting to membrane (GO:0006612) | 3.33804863 |
62 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 3.31645721 |
63 | establishment of viral latency (GO:0019043) | 3.31341067 |
64 | CTP biosynthetic process (GO:0006241) | 3.29863330 |
65 | CTP metabolic process (GO:0046036) | 3.29863330 |
66 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 3.27757990 |
67 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 3.26145156 |
68 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 3.25953772 |
69 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.25332396 |
70 | mitochondrial transport (GO:0006839) | 3.24030506 |
71 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.22682172 |
72 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.22114497 |
73 | negative regulation of ligase activity (GO:0051352) | 3.21932478 |
74 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.21932478 |
75 | protein targeting to mitochondrion (GO:0006626) | 3.17669707 |
76 | cellular protein complex disassembly (GO:0043624) | 3.15396756 |
77 | positive regulation of cell cycle arrest (GO:0071158) | 3.14517538 |
78 | regulation of ligase activity (GO:0051340) | 3.12940791 |
79 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.12569151 |
80 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.12569151 |
81 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.12289290 |
82 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.12289290 |
83 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.12289290 |
84 | oxidative phosphorylation (GO:0006119) | 3.11320259 |
85 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.10695637 |
86 | nucleotide transmembrane transport (GO:1901679) | 3.09991596 |
87 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.09236623 |
88 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.07979460 |
89 | hydrogen ion transmembrane transport (GO:1902600) | 3.07931837 |
90 | nucleoside triphosphate biosynthetic process (GO:0009142) | 3.06795549 |
91 | 7-methylguanosine mRNA capping (GO:0006370) | 3.06758361 |
92 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 3.05936318 |
93 | UTP metabolic process (GO:0046051) | 3.05050127 |
94 | establishment of protein localization to mitochondrion (GO:0072655) | 3.04450111 |
95 | regulation of oxidative phosphorylation (GO:0002082) | 3.02305186 |
96 | ATP biosynthetic process (GO:0006754) | 3.02066013 |
97 | translational initiation (GO:0006413) | 3.00996795 |
98 | RNA capping (GO:0036260) | 2.99801968 |
99 | 7-methylguanosine RNA capping (GO:0009452) | 2.99801968 |
100 | negative regulation of protein ubiquitination (GO:0031397) | 2.99274214 |
101 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 2.98562691 |
102 | cellular component biogenesis (GO:0044085) | 2.97728560 |
103 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.97214696 |
104 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.95739139 |
105 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.95739139 |
106 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.94309245 |
107 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.94309245 |
108 | intracellular protein transmembrane import (GO:0044743) | 2.93713435 |
109 | inner mitochondrial membrane organization (GO:0007007) | 2.92411113 |
110 | protein peptidyl-prolyl isomerization (GO:0000413) | 2.91896818 |
111 | pyrimidine ribonucleoside triphosphate biosynthetic process (GO:0009209) | 2.90388274 |
112 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.90266607 |
113 | spliceosomal snRNP assembly (GO:0000387) | 2.90122684 |
114 | purine nucleoside monophosphate biosynthetic process (GO:0009127) | 2.89522778 |
115 | purine ribonucleoside monophosphate biosynthetic process (GO:0009168) | 2.89522778 |
116 | regulation of cellular amine metabolic process (GO:0033238) | 2.89398835 |
117 | protein-cofactor linkage (GO:0018065) | 2.87896636 |
118 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.87001752 |
119 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.86091523 |
120 | ribosomal large subunit biogenesis (GO:0042273) | 2.80301240 |
121 | iron-sulfur cluster assembly (GO:0016226) | 2.80240797 |
122 | metallo-sulfur cluster assembly (GO:0031163) | 2.80240797 |
123 | deoxyribonucleoside diphosphate metabolic process (GO:0009186) | 2.79729313 |
124 | protein localization to mitochondrion (GO:0070585) | 2.79324828 |
125 | proton transport (GO:0015992) | 2.78996951 |
Rank | Gene Set | Z-score |
---|---|---|
1 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 5.11557199 |
2 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 5.09437999 |
3 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 4.81239988 |
4 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 4.28874643 |
5 | * EST1_17652178_ChIP-ChIP_JURKAT_Human | 4.03774688 |
6 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.76734450 |
7 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.53937085 |
8 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 3.53504863 |
9 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 3.30834996 |
10 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.30159547 |
11 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.18489437 |
12 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.18220422 |
13 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 3.09669779 |
14 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.03392272 |
15 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.99621443 |
16 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.94163189 |
17 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.75656053 |
18 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.63189750 |
19 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.56997374 |
20 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 2.38449028 |
21 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.37503882 |
22 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.34466782 |
23 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.21619948 |
24 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.09043699 |
25 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.05907083 |
26 | * THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.05733054 |
27 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.04354273 |
28 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 2.01446966 |
29 | * ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.99358166 |
30 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.98384005 |
31 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.96179952 |
32 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.93588271 |
33 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.91966334 |
34 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.89325984 |
35 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.88366463 |
36 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.72766232 |
37 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.71442492 |
38 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.69898183 |
39 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.64288567 |
40 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.63927903 |
41 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.62772201 |
42 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.57777135 |
43 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.51852984 |
44 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.46800714 |
45 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.46389256 |
46 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.43542709 |
47 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.41078608 |
48 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.38620989 |
49 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.37084711 |
50 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.36303224 |
51 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.33954259 |
52 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.31512044 |
53 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.27726142 |
54 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27026489 |
55 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.24897436 |
56 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21753240 |
57 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.21459556 |
58 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.18674969 |
59 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.18278841 |
60 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.12225156 |
61 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.10129506 |
62 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10036882 |
63 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.08602808 |
64 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.07988813 |
65 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.06069327 |
66 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.05066194 |
67 | * CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.03676984 |
68 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.03358663 |
69 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.02040570 |
70 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.00490894 |
71 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.00092904 |
72 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.99617663 |
73 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.98994988 |
74 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.98690440 |
75 | * SPI1_23547873_ChIP-Seq_NB4_Human | 0.98158689 |
76 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.97162438 |
77 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.96458394 |
78 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95127809 |
79 | VDR_22108803_ChIP-Seq_LS180_Human | 0.93837114 |
80 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.93431907 |
81 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.92793889 |
82 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.92714657 |
83 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92386606 |
84 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.92154611 |
85 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.91607290 |
86 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.90620657 |
87 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.90567160 |
88 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.90350819 |
89 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.89890075 |
90 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.89761433 |
91 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.88695344 |
92 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.88408364 |
93 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.86709017 |
94 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.85097759 |
95 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.84886519 |
96 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.84763371 |
97 | * TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.83472506 |
98 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.82810240 |
99 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.82810240 |
100 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.82109395 |
101 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.82071806 |
102 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.81921104 |
103 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.81715319 |
104 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.81557363 |
105 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.81194473 |
106 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.80562092 |
107 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.80355080 |
108 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.80100963 |
109 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.79846883 |
110 | AR_20517297_ChIP-Seq_VCAP_Human | 0.79632926 |
111 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.78961611 |
112 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.78948713 |
113 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.78464275 |
114 | EWS_26573619_Chip-Seq_HEK293_Human | 0.77584852 |
115 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.76597546 |
116 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.76330713 |
117 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.76114483 |
118 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.75969739 |
119 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.75538781 |
120 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.75219922 |
121 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.74200901 |
122 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.73588050 |
123 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.72871280 |
124 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.72735602 |
125 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.71600683 |
126 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.71275298 |
127 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.71071900 |
128 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.70314574 |
129 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.67028502 |
130 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.66912042 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0009379_abnormal_foot_pigmentation | 3.65756982 |
2 | MP0010386_abnormal_urinary_bladder | 3.17552259 |
3 | MP0005379_endocrine/exocrine_gland_phen | 3.00131942 |
4 | MP0003186_abnormal_redox_activity | 2.94591967 |
5 | MP0003806_abnormal_nucleotide_metabolis | 2.72424123 |
6 | MP0002163_abnormal_gland_morphology | 2.63374019 |
7 | MP0004043_abnormal_pH_regulation | 2.42652576 |
8 | MP0003724_increased_susceptibility_to | 2.39180110 |
9 | MP0003786_premature_aging | 2.35604509 |
10 | MP0008875_abnormal_xenobiotic_pharmacok | 2.32733131 |
11 | MP0001529_abnormal_vocalization | 2.32148267 |
12 | MP0001986_abnormal_taste_sensitivity | 2.30232030 |
13 | MP0003195_calcinosis | 2.26441751 |
14 | MP0003693_abnormal_embryo_hatching | 2.25055281 |
15 | MP0008058_abnormal_DNA_repair | 2.24607524 |
16 | MP0002638_abnormal_pupillary_reflex | 2.18119441 |
17 | MP0002693_abnormal_pancreas_physiology | 2.09059240 |
18 | MP0001905_abnormal_dopamine_level | 1.98184343 |
19 | MP0006036_abnormal_mitochondrial_physio | 1.96117005 |
20 | MP0000372_irregular_coat_pigmentation | 1.91802248 |
21 | MP0005220_abnormal_exocrine_pancreas | 1.86754381 |
22 | MP0005671_abnormal_response_to | 1.82536953 |
23 | MP0003183_abnormal_peptide_metabolism | 1.82322502 |
24 | MP0005058_abnormal_lysosome_morphology | 1.82162627 |
25 | MP0002148_abnormal_hypersensitivity_rea | 1.81750584 |
26 | MP0002933_joint_inflammation | 1.79847268 |
27 | MP0005464_abnormal_platelet_physiology | 1.79115370 |
28 | MP0005408_hypopigmentation | 1.77185271 |
29 | MP0005636_abnormal_mineral_homeostasis | 1.76188001 |
30 | MP0006054_spinal_hemorrhage | 1.75891801 |
31 | MP0009333_abnormal_splenocyte_physiolog | 1.74658494 |
32 | MP0005084_abnormal_gallbladder_morpholo | 1.72589752 |
33 | MP0002876_abnormal_thyroid_physiology | 1.72337512 |
34 | MP0000358_abnormal_cell_content/ | 1.67407663 |
35 | MP0001542_abnormal_bone_strength | 1.66256952 |
36 | MP0004147_increased_porphyrin_level | 1.65336169 |
37 | MP0001764_abnormal_homeostasis | 1.64730473 |
38 | MP0009785_altered_susceptibility_to | 1.64388576 |
39 | MP0002139_abnormal_hepatobiliary_system | 1.60698270 |
40 | MP0000013_abnormal_adipose_tissue | 1.60147675 |
41 | MP0002938_white_spotting | 1.55626306 |
42 | MP0005365_abnormal_bile_salt | 1.53846404 |
43 | MP0001944_abnormal_pancreas_morphology | 1.53519891 |
44 | MP0000678_abnormal_parathyroid_gland | 1.52699328 |
45 | MP0005410_abnormal_fertilization | 1.47836982 |
46 | MP0008438_abnormal_cutaneous_collagen | 1.43956211 |
47 | * MP0004957_abnormal_blastocyst_morpholog | 1.43023334 |
48 | MP0002132_abnormal_respiratory_system | 1.42998323 |
49 | MP0009697_abnormal_copulation | 1.40208629 |
50 | MP0000613_abnormal_salivary_gland | 1.39062658 |
51 | MP0006276_abnormal_autonomic_nervous | 1.38079367 |
52 | MP0010030_abnormal_orbit_morphology | 1.37305576 |
53 | MP0008007_abnormal_cellular_replicative | 1.37222230 |
54 | MP0009643_abnormal_urine_homeostasis | 1.36319713 |
55 | MP0001664_abnormal_digestion | 1.35764782 |
56 | MP0003866_abnormal_defecation | 1.32511897 |
57 | MP0001835_abnormal_antigen_presentation | 1.29498307 |
58 | MP0003950_abnormal_plasma_membrane | 1.29034588 |
59 | * MP0008932_abnormal_embryonic_tissue | 1.28851018 |
60 | MP0002282_abnormal_trachea_morphology | 1.26658340 |
61 | MP0008872_abnormal_physiological_respon | 1.25754547 |
62 | MP0005085_abnormal_gallbladder_physiolo | 1.24810610 |
63 | MP0000343_altered_response_to | 1.24459740 |
64 | MP0006072_abnormal_retinal_apoptosis | 1.22186664 |
65 | MP0003763_abnormal_thymus_physiology | 1.21148965 |
66 | MP0008995_early_reproductive_senescence | 1.21127200 |
67 | MP0005000_abnormal_immune_tolerance | 1.21076405 |
68 | MP0001984_abnormal_olfaction | 1.19631766 |
69 | MP0005025_abnormal_response_to | 1.19592236 |
70 | MP0005253_abnormal_eye_physiology | 1.17184890 |
71 | MP0001666_abnormal_nutrient_absorption | 1.16116919 |
72 | MP0003941_abnormal_skin_development | 1.15915927 |
73 | MP0008004_abnormal_stomach_pH | 1.15265419 |
74 | MP0000538_abnormal_urinary_bladder | 1.13999597 |
75 | MP0005075_abnormal_melanosome_morpholog | 1.13495681 |
76 | MP0002102_abnormal_ear_morphology | 1.12269337 |
77 | MP0005165_increased_susceptibility_to | 1.11500907 |
78 | MP0002090_abnormal_vision | 1.11479511 |
79 | MP0003718_maternal_effect | 1.09773268 |
80 | MP0001853_heart_inflammation | 1.09616095 |
81 | MP0003136_yellow_coat_color | 1.09556642 |
82 | MP0000462_abnormal_digestive_system | 1.07467048 |
83 | MP0004019_abnormal_vitamin_homeostasis | 1.07350804 |
84 | MP0000681_abnormal_thyroid_gland | 1.06370532 |
85 | MP0005360_urolithiasis | 1.06200160 |
86 | MP0005503_abnormal_tendon_morphology | 1.05176116 |
87 | MP0005645_abnormal_hypothalamus_physiol | 1.04125777 |
88 | MP0003656_abnormal_erythrocyte_physiolo | 1.04090065 |
89 | MP0002277_abnormal_respiratory_mucosa | 1.04042698 |
90 | MP0002234_abnormal_pharynx_morphology | 1.03337299 |
91 | MP0005083_abnormal_biliary_tract | 1.02475035 |
92 | MP0001790_abnormal_immune_system | 1.01524794 |
93 | MP0005387_immune_system_phenotype | 1.01524794 |
94 | MP0001533_abnormal_skeleton_physiology | 0.98941164 |
95 | MP0005409_darkened_coat_color | 0.97333703 |
96 | MP0000685_abnormal_immune_system | 0.96741263 |
97 | MP0008469_abnormal_protein_level | 0.95319881 |
98 | MP0002295_abnormal_pulmonary_circulatio | 0.95034437 |
99 | MP0008789_abnormal_olfactory_epithelium | 0.94547413 |
100 | MP0001756_abnormal_urination | 0.94473189 |
101 | MP0000230_abnormal_systemic_arterial | 0.93429326 |
102 | MP0002419_abnormal_innate_immunity | 0.93389725 |
103 | MP0005551_abnormal_eye_electrophysiolog | 0.92463300 |
104 | MP0004142_abnormal_muscle_tone | 0.92079391 |
105 | MP0001881_abnormal_mammary_gland | 0.90309918 |
106 | MP0001845_abnormal_inflammatory_respons | 0.90183255 |
107 | MP0006035_abnormal_mitochondrial_morpho | 0.89941414 |
108 | MP0004272_abnormal_basement_membrane | 0.89849301 |
109 | MP0002723_abnormal_immune_serum | 0.89787263 |
110 | MP0005381_digestive/alimentary_phenotyp | 0.89452077 |
111 | MP0002837_dystrophic_cardiac_calcinosis | 0.88720329 |
112 | MP0002736_abnormal_nociception_after | 0.87347490 |
113 | MP0008873_increased_physiological_sensi | 0.86876010 |
114 | MP0005646_abnormal_pituitary_gland | 0.86820153 |
115 | MP0003436_decreased_susceptibility_to | 0.85177122 |
116 | MP0004782_abnormal_surfactant_physiolog | 0.84529018 |
117 | MP0000516_abnormal_urinary_system | 0.84491803 |
118 | MP0005367_renal/urinary_system_phenotyp | 0.84491803 |
119 | MP0005171_absent_coat_pigmentation | 0.82671050 |
120 | MP0002405_respiratory_system_inflammati | 0.81508122 |
121 | MP0003959_abnormal_lean_body | 0.79556803 |
122 | MP0003011_delayed_dark_adaptation | 0.79028728 |
123 | MP0010094_abnormal_chromosome_stability | 0.78433916 |
124 | MP0001765_abnormal_ion_homeostasis | 0.78298859 |
125 | MP0002095_abnormal_skin_pigmentation | 0.77717364 |
126 | MP0001879_abnormal_lymphatic_vessel | 0.77622836 |
127 | MP0001663_abnormal_digestive_system | 0.76758420 |
128 | MP0002420_abnormal_adaptive_immunity | 0.76347392 |
129 | MP0010329_abnormal_lipoprotein_level | 0.76135914 |
130 | MP0003868_abnormal_feces_composition | 0.76088809 |
131 | MP0005310_abnormal_salivary_gland | 0.75924283 |
132 | MP0005332_abnormal_amino_acid | 0.75804195 |
133 | MP0003795_abnormal_bone_structure | 0.75565401 |
134 | MP0003077_abnormal_cell_cycle | 0.75537085 |
135 | MP0001819_abnormal_immune_cell | 0.75475994 |
136 | MP0006082_CNS_inflammation | 0.74823729 |
137 | MP0002909_abnormal_adrenal_gland | 0.74590687 |
138 | MP0005319_abnormal_enzyme/_coenzyme | 0.74469932 |
139 | MP0005376_homeostasis/metabolism_phenot | 0.72151961 |
140 | MP0003075_altered_response_to | 0.71750544 |
141 | MP0009780_abnormal_chondrocyte_physiolo | 0.70179742 |
142 | MP0000639_abnormal_adrenal_gland | 0.70079382 |
143 | MP0004133_heterotaxia | 0.70009246 |
144 | MP0005390_skeleton_phenotype | 0.69945160 |
145 | MP0002160_abnormal_reproductive_system | 0.69776946 |
146 | MP0003122_maternal_imprinting | 0.69002595 |
147 | MP0000465_gastrointestinal_hemorrhage | 0.68886305 |
148 | MP0005389_reproductive_system_phenotype | 0.68373783 |
149 | MP0001293_anophthalmia | 0.68329109 |
150 | MP0000490_abnormal_crypts_of | 0.67810041 |
151 | MP0005395_other_phenotype | 0.67067135 |
152 | MP0004215_abnormal_myocardial_fiber | 0.66455960 |
153 | MP0003279_aneurysm | 0.64031091 |
154 | MP0009763_increased_sensitivity_to | 0.63394123 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Acute necrotizing encephalopathy (HP:0006965) | 5.49995478 |
2 | Mitochondrial inheritance (HP:0001427) | 5.18294196 |
3 | Abnormal mitochondria in muscle tissue (HP:0008316) | 5.01407137 |
4 | Hepatocellular necrosis (HP:0001404) | 4.73624980 |
5 | Hepatic necrosis (HP:0002605) | 4.60116274 |
6 | Acute encephalopathy (HP:0006846) | 4.55827915 |
7 | Increased CSF lactate (HP:0002490) | 4.31952222 |
8 | Progressive macrocephaly (HP:0004481) | 4.26139718 |
9 | Renal Fanconi syndrome (HP:0001994) | 3.96178261 |
10 | Increased hepatocellular lipid droplets (HP:0006565) | 3.93390087 |
11 | Type I transferrin isoform profile (HP:0003642) | 3.90830718 |
12 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.76247324 |
13 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.76247324 |
14 | Lipid accumulation in hepatocytes (HP:0006561) | 3.62566431 |
15 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.55630013 |
16 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.55215772 |
17 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 3.46735683 |
18 | Abnormal protein N-linked glycosylation (HP:0012347) | 3.46735683 |
19 | Abnormal protein glycosylation (HP:0012346) | 3.46735683 |
20 | Abnormal glycosylation (HP:0012345) | 3.46735683 |
21 | Abnormal number of erythroid precursors (HP:0012131) | 3.34730267 |
22 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 3.29555795 |
23 | 3-Methylglutaconic aciduria (HP:0003535) | 3.18685844 |
24 | Increased intramyocellular lipid droplets (HP:0012240) | 3.18683195 |
25 | Exertional dyspnea (HP:0002875) | 3.15211522 |
26 | Lactic acidosis (HP:0003128) | 3.04298198 |
27 | Respiratory failure (HP:0002878) | 3.02575651 |
28 | Aplastic anemia (HP:0001915) | 3.01092785 |
29 | Exercise intolerance (HP:0003546) | 2.99535271 |
30 | Increased serum lactate (HP:0002151) | 2.97394040 |
31 | Vacuolated lymphocytes (HP:0001922) | 2.95169229 |
32 | Abnormality of renal resorption (HP:0011038) | 2.90291858 |
33 | Cerebral edema (HP:0002181) | 2.87932367 |
34 | Irregular epiphyses (HP:0010582) | 2.79203099 |
35 | Increased muscle lipid content (HP:0009058) | 2.77292854 |
36 | Congenital, generalized hypertrichosis (HP:0004540) | 2.74793254 |
37 | Hypothermia (HP:0002045) | 2.70789847 |
38 | Generalized aminoaciduria (HP:0002909) | 2.67668076 |
39 | Glycosuria (HP:0003076) | 2.67450873 |
40 | Abnormality of urine glucose concentration (HP:0011016) | 2.67450873 |
41 | Reduced antithrombin III activity (HP:0001976) | 2.65550674 |
42 | Respiratory difficulties (HP:0002880) | 2.47610151 |
43 | Leukodystrophy (HP:0002415) | 2.45284264 |
44 | Methylmalonic acidemia (HP:0002912) | 2.44566049 |
45 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.43697375 |
46 | Optic disc pallor (HP:0000543) | 2.42865851 |
47 | Hyperphosphaturia (HP:0003109) | 2.41588125 |
48 | Beaking of vertebral bodies (HP:0004568) | 2.39358817 |
49 | Abnormality of placental membranes (HP:0011409) | 2.37389788 |
50 | Amniotic constriction ring (HP:0009775) | 2.37389788 |
51 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.35298145 |
52 | Oral leukoplakia (HP:0002745) | 2.32867622 |
53 | Macrocytic anemia (HP:0001972) | 2.27620463 |
54 | Poor head control (HP:0002421) | 2.27235565 |
55 | Nausea (HP:0002018) | 2.25733614 |
56 | Reticulocytopenia (HP:0001896) | 2.23688570 |
57 | X-linked dominant inheritance (HP:0001423) | 2.17228236 |
58 | Abnormality of methionine metabolism (HP:0010901) | 2.17038884 |
59 | Degeneration of anterior horn cells (HP:0002398) | 2.16832626 |
60 | Abnormality of the anterior horn cell (HP:0006802) | 2.16832626 |
61 | Microvesicular hepatic steatosis (HP:0001414) | 2.16815013 |
62 | Abnormal pupillary function (HP:0007686) | 2.15343700 |
63 | Progressive neurologic deterioration (HP:0002344) | 2.06557054 |
64 | Flat capital femoral epiphysis (HP:0003370) | 2.06385528 |
65 | Hypoplasia of the uterus (HP:0000013) | 2.06279125 |
66 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.05767169 |
67 | Purpura (HP:0000979) | 2.02230092 |
68 | Sparse eyelashes (HP:0000653) | 2.01863899 |
69 | Irregular vertebral endplates (HP:0003301) | 2.01293049 |
70 | Neuroendocrine neoplasm (HP:0100634) | 2.00834540 |
71 | CNS demyelination (HP:0007305) | 2.00799738 |
72 | Pancytopenia (HP:0001876) | 1.97386272 |
73 | Abnormal tarsal ossification (HP:0008369) | 1.95108528 |
74 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.93040204 |
75 | Increased serum pyruvate (HP:0003542) | 1.92770059 |
76 | Abnormality of glycolysis (HP:0004366) | 1.92770059 |
77 | Blindness (HP:0000618) | 1.91431992 |
78 | Pallor (HP:0000980) | 1.91111460 |
79 | Hypoglycemic coma (HP:0001325) | 1.88652791 |
80 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.88347737 |
81 | Hyperglycinemia (HP:0002154) | 1.88022023 |
82 | Renal tubular dysfunction (HP:0000124) | 1.86354927 |
83 | Emotional lability (HP:0000712) | 1.85112735 |
84 | Abnormal urine phosphate concentration (HP:0012599) | 1.83613740 |
85 | Epiphyseal dysplasia (HP:0002656) | 1.82921725 |
86 | Lethargy (HP:0001254) | 1.82756768 |
87 | Pheochromocytoma (HP:0002666) | 1.78145961 |
88 | Methylmalonic aciduria (HP:0012120) | 1.78050833 |
89 | Abnormality of midbrain morphology (HP:0002418) | 1.77735151 |
90 | Molar tooth sign on MRI (HP:0002419) | 1.77735151 |
91 | Delayed epiphyseal ossification (HP:0002663) | 1.76316064 |
92 | Abnormality of magnesium homeostasis (HP:0004921) | 1.75267195 |
93 | Symptomatic seizures (HP:0011145) | 1.74017559 |
94 | Dysostosis multiplex (HP:0000943) | 1.71538575 |
95 | Abnormality of serum amino acid levels (HP:0003112) | 1.69541248 |
96 | Parakeratosis (HP:0001036) | 1.68875304 |
97 | True hermaphroditism (HP:0010459) | 1.67514693 |
98 | Abnormality of the vertebral endplates (HP:0005106) | 1.66514666 |
99 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.65827412 |
100 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.65732617 |
101 | Abnormality of alanine metabolism (HP:0010916) | 1.65732617 |
102 | Hyperalaninemia (HP:0003348) | 1.65732617 |
103 | Vomiting (HP:0002013) | 1.65489860 |
104 | Menorrhagia (HP:0000132) | 1.65476670 |
105 | Cerebral hypomyelination (HP:0006808) | 1.65464355 |
106 | Dicarboxylic aciduria (HP:0003215) | 1.65365203 |
107 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.65365203 |
108 | Large for gestational age (HP:0001520) | 1.65187445 |
109 | Disproportionate short-trunk short stature (HP:0003521) | 1.64164819 |
110 | Rough bone trabeculation (HP:0100670) | 1.63176313 |
111 | Abnormality of the femoral head (HP:0003368) | 1.63068651 |
112 | Opisthotonus (HP:0002179) | 1.62704520 |
113 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.62696211 |
114 | Pancreatic cysts (HP:0001737) | 1.62170665 |
115 | Hepatosplenomegaly (HP:0001433) | 1.61897793 |
116 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.61822103 |
117 | Megaloblastic anemia (HP:0001889) | 1.57821607 |
118 | Carpal bone hypoplasia (HP:0001498) | 1.57362960 |
119 | Testicular atrophy (HP:0000029) | 1.56964592 |
120 | Pancreatic fibrosis (HP:0100732) | 1.54441168 |
121 | Renal cortical cysts (HP:0000803) | 1.54064483 |
122 | Metaphyseal irregularity (HP:0003025) | 1.53968499 |
123 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.53579982 |
124 | Small epiphyses (HP:0010585) | 1.53556829 |
125 | 11 pairs of ribs (HP:0000878) | 1.53356807 |
126 | Redundant skin (HP:0001582) | 1.53182348 |
127 | Hypokinesia (HP:0002375) | 1.53013520 |
128 | Medial flaring of the eyebrow (HP:0010747) | 1.52697939 |
129 | Petechiae (HP:0000967) | 1.52409327 |
130 | Proximal tubulopathy (HP:0000114) | 1.52221446 |
131 | IgM deficiency (HP:0002850) | 1.50535277 |
132 | Abnormality of the intrinsic pathway (HP:0010989) | 1.50242500 |
Rank | Gene Set | Z-score |
---|---|---|
1 | VRK2 | 5.72147865 |
2 | NME2 | 4.27618379 |
3 | STK16 | 4.19438279 |
4 | EIF2AK3 | 3.00535437 |
5 | PIM2 | 2.92767101 |
6 | NME1 | 2.72059215 |
7 | MAPK15 | 2.60590549 |
8 | VRK1 | 2.39806116 |
9 | IRAK3 | 2.27181384 |
10 | MYLK | 2.11715364 |
11 | MAP3K12 | 2.01887413 |
12 | MST4 | 1.91890190 |
13 | EIF2AK1 | 1.87879079 |
14 | BCKDK | 1.86608444 |
15 | ARAF | 1.84516178 |
16 | TESK1 | 1.83223917 |
17 | KDR | 1.79624372 |
18 | NUAK1 | 1.78824850 |
19 | MAP4K2 | 1.75794440 |
20 | BUB1 | 1.74894139 |
21 | BMPR1B | 1.72727296 |
22 | LIMK1 | 1.70249302 |
23 | TESK2 | 1.69659266 |
24 | PASK | 1.64866209 |
25 | NEK1 | 1.58345255 |
26 | MUSK | 1.56127682 |
27 | IRAK4 | 1.50257449 |
28 | TRIM28 | 1.48266691 |
29 | PLK3 | 1.40707515 |
30 | IRAK1 | 1.38024227 |
31 | BRAF | 1.35442898 |
32 | WNK4 | 1.33172891 |
33 | TAF1 | 1.30645376 |
34 | TEC | 1.30545526 |
35 | PBK | 1.30244630 |
36 | TXK | 1.30038618 |
37 | ADRBK2 | 1.28967571 |
38 | ERN1 | 1.28609939 |
39 | CDK8 | 1.24029924 |
40 | PDK2 | 1.22426166 |
41 | TAOK3 | 1.20184622 |
42 | PIK3CG | 1.16698416 |
43 | DAPK1 | 1.15652924 |
44 | PLK4 | 1.09247898 |
45 | STK39 | 1.07212026 |
46 | MAP3K3 | 1.05336044 |
47 | MAP2K7 | 1.04105394 |
48 | CSNK1G1 | 1.03069832 |
49 | MAPKAPK3 | 1.02700173 |
50 | DAPK3 | 1.02536975 |
51 | PAK4 | 1.00646770 |
52 | TLK1 | 0.99668449 |
53 | TNIK | 0.99337376 |
54 | MAP3K11 | 0.97798387 |
55 | GRK7 | 0.97526315 |
56 | CSNK1G2 | 0.96315707 |
57 | DYRK2 | 0.95046913 |
58 | MAP2K2 | 0.93432036 |
59 | ZAK | 0.91387945 |
60 | FLT3 | 0.91359669 |
61 | PRKG2 | 0.90301366 |
62 | PLK2 | 0.86556082 |
63 | MAPKAPK5 | 0.85352510 |
64 | ZAP70 | 0.85340370 |
65 | NLK | 0.85274773 |
66 | TBK1 | 0.82187404 |
67 | SRPK1 | 0.80967578 |
68 | SCYL2 | 0.79335269 |
69 | SIK3 | 0.78223638 |
70 | BCR | 0.77026566 |
71 | CSNK1A1L | 0.76291029 |
72 | TSSK6 | 0.73541926 |
73 | NEK6 | 0.73377559 |
74 | IRAK2 | 0.73257801 |
75 | CAMKK2 | 0.71435070 |
76 | INSRR | 0.71422862 |
77 | BTK | 0.69902447 |
78 | WNK3 | 0.69025044 |
79 | CDC7 | 0.68432371 |
80 | ABL2 | 0.67479211 |
81 | IKBKE | 0.62420421 |
82 | IKBKB | 0.62185899 |
83 | LRRK2 | 0.61921857 |
84 | CDK19 | 0.60768442 |
85 | GRK1 | 0.59508576 |
86 | TIE1 | 0.59470712 |
87 | OBSCN | 0.58872083 |
88 | OXSR1 | 0.58218274 |
89 | CSNK1G3 | 0.58161412 |
90 | EIF2AK2 | 0.58073572 |
91 | GRK5 | 0.57638680 |
92 | STK24 | 0.56140357 |
93 | BMPR2 | 0.56041500 |
94 | CAMK2D | 0.55163841 |
95 | JAK3 | 0.54919323 |
96 | STK38L | 0.53994887 |
97 | AURKA | 0.53839917 |
98 | CSNK2A1 | 0.53739761 |
99 | ERBB4 | 0.53340849 |
100 | MAP4K1 | 0.53301332 |
101 | WEE1 | 0.52891236 |
102 | LYN | 0.52509309 |
103 | HIPK2 | 0.52508036 |
104 | PRKCI | 0.52290416 |
105 | ERBB3 | 0.50964553 |
106 | BRSK2 | 0.50780907 |
107 | RPS6KA5 | 0.50397688 |
108 | ILK | 0.50074804 |
109 | PLK1 | 0.49745935 |
110 | EPHB2 | 0.49368609 |
111 | PAK1 | 0.47747489 |
112 | AKT3 | 0.47555035 |
113 | BRSK1 | 0.47309965 |
114 | STK4 | 0.46085113 |
115 | ACVR1B | 0.45537179 |
116 | LMTK2 | 0.44426133 |
117 | TTK | 0.44320251 |
118 | CDK3 | 0.43720947 |
119 | CAMK2G | 0.43608757 |
120 | MET | 0.43080342 |
121 | KIT | 0.41842241 |
122 | SYK | 0.41647403 |
123 | PRKCD | 0.41113792 |
124 | AURKB | 0.40060749 |
125 | PRKCG | 0.39505120 |
126 | EPHA2 | 0.38530438 |
127 | ADRBK1 | 0.38209949 |
128 | PRKCE | 0.38124262 |
129 | PAK3 | 0.36452555 |
130 | CSNK2A2 | 0.36053597 |
131 | FER | 0.35749071 |
132 | CCNB1 | 0.35612634 |
133 | PTK2B | 0.35567307 |
134 | MAP3K14 | 0.35504504 |
135 | BLK | 0.34233589 |
136 | DYRK3 | 0.33814483 |
137 | MAP3K5 | 0.31977712 |
138 | CSNK1A1 | 0.29320796 |
139 | PINK1 | 0.28803605 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Protein export_Homo sapiens_hsa03060 | 5.79801610 |
2 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 4.55695447 |
3 | Ribosome_Homo sapiens_hsa03010 | 4.12076137 |
4 | Proteasome_Homo sapiens_hsa03050 | 3.89104772 |
5 | Parkinsons disease_Homo sapiens_hsa05012 | 3.84907773 |
6 | Alzheimers disease_Homo sapiens_hsa05010 | 2.76104563 |
7 | Huntingtons disease_Homo sapiens_hsa05016 | 2.73395389 |
8 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.69474862 |
9 | RNA polymerase_Homo sapiens_hsa03020 | 2.65911394 |
10 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.60270953 |
11 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.23068658 |
12 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.82857487 |
13 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.82057363 |
14 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.64722303 |
15 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.64190592 |
16 | Other glycan degradation_Homo sapiens_hsa00511 | 1.59595660 |
17 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.56291536 |
18 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.50595644 |
19 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.49853892 |
20 | * Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.47062906 |
21 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.45808099 |
22 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.43069513 |
23 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.27576399 |
24 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.24709423 |
25 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.21964209 |
26 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.20998544 |
27 | DNA replication_Homo sapiens_hsa03030 | 1.12184300 |
28 | * N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.11776616 |
29 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.10803214 |
30 | Basal transcription factors_Homo sapiens_hsa03022 | 1.09130912 |
31 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.08634345 |
32 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.07782123 |
33 | Purine metabolism_Homo sapiens_hsa00230 | 1.06165140 |
34 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.01552101 |
35 | Mismatch repair_Homo sapiens_hsa03430 | 1.01294088 |
36 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.01059005 |
37 | Sulfur relay system_Homo sapiens_hsa04122 | 1.00622446 |
38 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.97876272 |
39 | Homologous recombination_Homo sapiens_hsa03440 | 0.95649966 |
40 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.93978096 |
41 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.93602416 |
42 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.93544792 |
43 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.92873775 |
44 | Spliceosome_Homo sapiens_hsa03040 | 0.91261087 |
45 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.90896612 |
46 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.88311981 |
47 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.82743382 |
48 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.80465521 |
49 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.76310130 |
50 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.75605525 |
51 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.73527164 |
52 | Lysosome_Homo sapiens_hsa04142 | 0.72954049 |
53 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.71868369 |
54 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.69458651 |
55 | Base excision repair_Homo sapiens_hsa03410 | 0.68770064 |
56 | Galactose metabolism_Homo sapiens_hsa00052 | 0.67450210 |
57 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.65835087 |
58 | Carbon metabolism_Homo sapiens_hsa01200 | 0.65092368 |
59 | RNA degradation_Homo sapiens_hsa03018 | 0.64363721 |
60 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.63701558 |
61 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.63623758 |
62 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.63463153 |
63 | Histidine metabolism_Homo sapiens_hsa00340 | 0.62434619 |
64 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.61662331 |
65 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.59594134 |
66 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.58918783 |
67 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.58683734 |
68 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.56986357 |
69 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.56649483 |
70 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.56229569 |
71 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.55517201 |
72 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.54339174 |
73 | Mineral absorption_Homo sapiens_hsa04978 | 0.54317765 |
74 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.53224303 |
75 | Allograft rejection_Homo sapiens_hsa05330 | 0.52140700 |
76 | Phagosome_Homo sapiens_hsa04145 | 0.52019121 |
77 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.51824751 |
78 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.51018339 |
79 | Asthma_Homo sapiens_hsa05310 | 0.50457840 |
80 | Peroxisome_Homo sapiens_hsa04146 | 0.49566231 |
81 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.49545773 |
82 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.49539635 |
83 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.49074598 |
84 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.48718238 |
85 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.48125192 |
86 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.48075411 |
87 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.47878889 |
88 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.47875375 |
89 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.46270756 |
90 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.46255603 |
91 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.45741700 |
92 | Retinol metabolism_Homo sapiens_hsa00830 | 0.44881782 |
93 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.44569570 |
94 | Legionellosis_Homo sapiens_hsa05134 | 0.44484320 |
95 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.44196855 |
96 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.43994079 |
97 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.43559593 |
98 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.43271526 |
99 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.42518320 |
100 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.38780897 |
101 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.38205904 |
102 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.37261594 |
103 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.37184523 |
104 | Phototransduction_Homo sapiens_hsa04744 | 0.36772925 |
105 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.35119714 |
106 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.33739126 |
107 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.31671544 |
108 | RNA transport_Homo sapiens_hsa03013 | 0.31293556 |
109 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.30777011 |
110 | Malaria_Homo sapiens_hsa05144 | 0.30463272 |
111 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.28971494 |
112 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.28193002 |
113 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.28017905 |
114 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.27635993 |
115 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.27061608 |
116 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.26220827 |
117 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.25117659 |
118 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.24995387 |
119 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.24890278 |
120 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.24534165 |
121 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.24016929 |
122 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.23483916 |
123 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.23285114 |
124 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.19852128 |
125 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.16363523 |
126 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.16044313 |